<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xml:lang="en" article-type="research-article" xmlns:xlink="http://www.w3.org/1999/xlink">
<?release-delay 0|0?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Molecular Medicine Reports</journal-id>
<journal-title-group>
<journal-title>Molecular Medicine Reports</journal-title>
</journal-title-group>
<issn pub-type="ppub">1791-2997</issn>
<issn pub-type="epub">1791-3004</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3892/mmr.2022.12681</article-id>
<article-id pub-id-type="publisher-id">MMR-25-05-12681</article-id>
<article-categories>
<subj-group>
<subject>Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Preserving mitochondrial function by inhibiting GRP75 ameliorates neuron injury under ischemic stroke</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author"><name><surname>Wen</surname><given-names>Bin</given-names></name>
<xref rid="af1-mmr-25-05-12681" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author"><name><surname>Xu</surname><given-names>Kai</given-names></name>
<xref rid="af1-mmr-25-05-12681" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author"><name><surname>Huang</surname><given-names>Rui</given-names></name>
<xref rid="af2-mmr-25-05-12681" ref-type="aff">2</xref></contrib>
<contrib contrib-type="author"><name><surname>Jiang</surname><given-names>Teng</given-names></name>
<xref rid="af2-mmr-25-05-12681" ref-type="aff">2</xref></contrib>
<contrib contrib-type="author"><name><surname>Wang</surname><given-names>Jian</given-names></name>
<xref rid="af2-mmr-25-05-12681" ref-type="aff">2</xref></contrib>
<contrib contrib-type="author"><name><surname>Chen</surname><given-names>Jiehui</given-names></name>
<xref rid="af1-mmr-25-05-12681" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author"><name><surname>Chen</surname><given-names>Juan</given-names></name>
<xref rid="af1-mmr-25-05-12681" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author"><name><surname>He</surname><given-names>Benhong</given-names></name>
<xref rid="af2-mmr-25-05-12681" ref-type="aff">2</xref>
<xref rid="c1-mmr-25-05-12681" ref-type="corresp"/></contrib>
</contrib-group>
<aff id="af1-mmr-25-05-12681"><label>1</label>Department of Biochemistry and Molecular Biology, School of Basic Medicine and the Collaborative Innovation Center for Brain Science, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, P.R. China</aff>
<aff id="af2-mmr-25-05-12681"><label>2</label>Department of Cardiovascular Medicine, Lichuan People&#x0027;s Hospital, Lichuan, Hubei 445400, P.R. China</aff>
<author-notes>
<corresp id="c1-mmr-25-05-12681"><italic>Correspondence to</italic>: Professor Benhong He, Department of Cardiovascular Medicine, Lichuan People&#x0027;s Hospital, 12 Longchuan Avenue, Lichuan, Hubei 445400, P.R. China, E-mail: <email>lczyyhbh@163.com</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<month>05</month>
<year>2022</year></pub-date>
<pub-date pub-type="epub">
<day>15</day>
<month>03</month>
<year>2022</year></pub-date>
<volume>25</volume>
<issue>5</issue>
<elocation-id>165</elocation-id>
<history>
<date date-type="received"><day>01</day><month>09</month><year>2021</year></date>
<date date-type="accepted"><day>17</day><month>01</month><year>2022</year></date>
</history>
<permissions>
<copyright-statement>Copyright: &#x00A9; Wen et al.</copyright-statement>
<copyright-year>2022</copyright-year>
<license license-type="open-access">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.</license-p></license>
</permissions>
<abstract>
<p>Ischemic stroke is a life-threatening disease, which is closely related to neuron damage during ischemia. Mitochondrial dysfunction is essentially involved in the pathophysiological process of ischemic stroke. Mitochondrial calcium overload contributes to the development of mitochondrial dysfunction. However, the underlying mechanisms of mitochondrial calcium overload are far from being fully revealed. In the present study, middle cerebral artery obstruction (MCAO) was performed <italic>in vivo</italic> and oxygen and glucose deprivation (OGD) <italic>in vitro</italic>. The results indicated that both MCAO and OGD induced significant mitochondrial dysfunction <italic>in vivo</italic> and <italic>in vitro</italic>. The mitochondria became fragmented under hypoxia conditions, accompanied with upregulation of the heat shock protein 75 kDa glucose-regulated protein (GRP75). Inhibition of GRP75 was able to effectively ameliorate mitochondrial calcium overload and preserve mitochondrial function, which may provide evidence for further translational studies of ischemic diseases.</p>
</abstract>
<kwd-group>
<kwd>GRP75</kwd>
<kwd>calcium overload</kwd>
<kwd>mitochondria-associated endoplasmic reticulum membrane</kwd>
<kwd>mitochondria</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>National Natural Science Foundation of China</funding-source>
<award-id>81873725 to JC</award-id>
</award-group>
<award-group>
<funding-source>Hubei Province&#x0027;s Outstanding, Medical Academic Leader program</funding-source>
<award-id>to BH</award-id>
</award-group>
<funding-statement>This work was supported by the National Natural Science Foundation of China (grant no. 81873725 to JC) and Hubei Province&#x0027;s Outstanding, Medical Academic Leader program (to BH).</funding-statement>
</funding-group>
</article-meta>
</front>
<body>
<sec sec-type="intro">
<title>Introduction</title>
<p>Ischemic stroke is a problematic health issue worldwide. The major pathophysiological interference of ischemic stroke is the sudden obstruction of cerebral arteries, which immediately causes neurons to suffer from hypoxia (<xref rid="b1-mmr-25-05-12681" ref-type="bibr">1</xref>,<xref rid="b2-mmr-25-05-12681" ref-type="bibr">2</xref>). As a highly energy-dependent organ, the brain is vulnerable to hypoxia, which is also the reason for the high mortality associated with ischemic stroke (<xref rid="b3-mmr-25-05-12681" ref-type="bibr">3</xref>). It is of great importance to understand the mechanisms of neuron injury under ischemic stroke conditions to provide a more precise interference to manage this condition.</p>
<p>Different mechanisms have been reported to be involved in the pathological process of ischemic stroke. Neuron apoptosis (<xref rid="b4-mmr-25-05-12681" ref-type="bibr">4</xref>), necrosis (<xref rid="b5-mmr-25-05-12681" ref-type="bibr">5</xref>) and even ferroptosis (<xref rid="b6-mmr-25-05-12681" ref-type="bibr">6</xref>) have important roles. Of note, disturbed energy supply is reported to be critical to hypoxia-induced neuron death (<xref rid="b7-mmr-25-05-12681" ref-type="bibr">7</xref>). This is understandable, since neurons are highly energy-dependent cells and provides hints that maintaining energy supply may be useful in treating ischemic stroke. In fact, Li <italic>et al</italic> (<xref rid="b8-mmr-25-05-12681" ref-type="bibr">8</xref>) reported that maintaining mitochondrial function prevented nicotine-induced exacerbation of ischemic brain damage, which indicated that mitochondrial function is involved in the pathological processes of ischemic stroke.</p>
<p>As the power factory of the cell, mitochondrial normal function is of importance for neuron survival (<xref rid="b9-mmr-25-05-12681" ref-type="bibr">9</xref>). Mitochondrial dysfunction is involved in several ischemic diseases, including ischemic stroke (<xref rid="b10-mmr-25-05-12681" ref-type="bibr">10</xref>), myocardial infarction (<xref rid="b11-mmr-25-05-12681" ref-type="bibr">11</xref>) and kidney infarction (<xref rid="b12-mmr-25-05-12681" ref-type="bibr">12</xref>). The oxidative phosphorylation processes inside the matrix of mitochondria provides the majority of energy to the cell. However, mitochondria are also vulnerable to stresses and this may result in mitochondrial dysfunction. The present study provided evidence that mitochondrial dysfunction is critically involved in ischemic stroke-induced neuron injury via mitochondrial calcium overload. 75 kDa glucose-regulated protein (GRP75) is a member of the heat shock protein (HSP) family and mediates endoplasmic reticulum (ER)-mitochondrial calcium transfer, maintaining mitochondrial calcium homeostasis (<xref rid="b13-mmr-25-05-12681" ref-type="bibr">13</xref>). However, the role of GRP75 in hypoxia-induced neuron damage has so far remained elusive. The present study examined whether inhibiting GRP75 may ameliorate excessive mitochondrial calcium overload and whether it may be a promising target in preventing hypoxia-induced neuron injury.</p>
</sec>
<sec sec-type="materials|methods">
<title>Materials and methods</title>
<sec>
<title/>
<sec>
<title>Agents</title>
<p>MKT077 (cat. no. HY-15096) was purchased from MedChemExpress. Penicillin-streptomycin mixed solution (cat. no. G4003), pancreatic enzyme (cat. no. G4001), primary antibody diluent (cat. no. G2025), phenylmethylsulphonyl fluoride (PMSF; cat. no. G2008), protein phosphatase inhibitors (cat. no. G2007), DMSO, minimal essential medium (MEM; cat. no. G4553) and 5X loading buffer (cat. no. G2013) were purchased from Wuhan Servicebio Technology Co., Ltd. High-glucose DMEM (cat. no. 10569010), glucose-free DMEM (cat. no. 10966025), Opti-MEM (cat. no. 31985062) and fetal bovine serum (FBS; cat. no. 10091148) were obtained from Gibco (Thermo Fisher Scientific, Inc.). The enhanced chemiluminescence (ECL) kit (cat. no. P0018FS) and bicinchoninic acid (BCA) assay kit (cat. no. P0010S) were purchased from Beyotime Institute of Biotechnology. Primary antibodies against &#x03B2;-actin (cat. no. AC026), GRP75 (cat. no. A112560), mitochondrial fission factor (MFF; cat. no. A8700), mitofusin (MFN)1 (cat. no. A9880), MFN2 (cat. no. A19678), dynamin-1-like protein (DRP1; cat. no. A17069), phosphorylated (p)-DRP1 (cat. no. AP0812) and hypoxia-inducible factor 1-alpha (HIF1&#x03B1;; cat. no. A11945) were purchased from ABclonal Biotech Co., Ltd. Horseradish peroxidase (HRP)-conjugated goat anti-rabbit IgG (cat. no. AS014) and HRP-conjugated goat anti-mouse (cat. no. AS003) were purchased from ABclonal Biotech Co., Ltd. Lipofectamine<sup>&#x00AE;</sup> 3000 transfection reagent (cat. no. L3000015) and MitoTracker<sup>&#x00AE;</sup> Deep Red FM kits (cat. no. M7531) were from Thermo Fisher Scientific, Inc.</p>
</sec>
<sec>
<title>Animals</title>
<p>Male C57BL/6 mice (age, 10 weeks; weight, 25&#x2013;30 g) were purchased from the Animal Experiment Center of Tongji Medical College, Huazhong University of Science and Technology (Wuhan, China). The mice were housed in a specific pathogen-free room with free access to rodent chow and water. The experimental protocol was reviewed and approved by the Animal Research and Care Committee of Tongji Medical College, Huazhong University of Science and Technology [Wuhan, China; no. SYXK(E)2016-0057].</p>
</sec>
<sec>
<title>Mouse middle cerebral artery obstruction (MCAO) model</title>
<p>A mouse model of MCAO was generated as reported previously with minor modifications (<xref rid="b14-mmr-25-05-12681" ref-type="bibr">14</xref>,<xref rid="b15-mmr-25-05-12681" ref-type="bibr">15</xref>). In brief, 14 mice were randomized into the control and MCAO groups (n=7 per group). Individual mice were intraperitoneally injected with 10&#x0025; chloral hydrate (350 mg/kg) and no peritonitis was present. When the mice were anesthetized, an incision was made in the neck of the mice. After careful exposure of the right external carotid artery (ECA), common carotid artery (CCA) and internal carotid artery (ICA), the CCA was clamped and the ECA was tied, followed by insertion of a 6&#x2013;0 monofilament nylon suture with a rounded tip from the CCA to the ICA to occlude the left MCA at its origin (&#x007E;10 mm) and the skin was sutured. The mice were kept on a heating pad to maintain their temperature at 37&#x00B0;C. After recovery from anesthesia, the mice were returned into their cages and they were euthanized at 8 h post-ischemia. The mice were decapitated without anesthesia and four brains were used for 2,3,5-triphenyltetrazolium chloride (TTC) staining and three were analyzed using transmission electron microscopy (TEM).</p>
</sec>
<sec>
<title>TTC staining</title>
<p>The mice were euthanized by decapitation at 8 h of ischemia and their brains were rapidly removed and frozen. The frozen brains were cut into 2-mm sections. The brain slices were stained with 2&#x0025; TTC solution with incubation at 37&#x00B0;C for 15 min. Subsequently, the brain slices were fixed with 10&#x0025; paraformaldehyde for 10 min. The percentage of infarct volume of the total brain volume in individual mice was measured using Image J software (v1.51j8) [National Institutes of Health (NIH)] in a blinded manner.</p>
</sec>
<sec>
<title>TEM</title>
<p>The mouse brain tissues were immersed in 2.5&#x0025; glutaraldehyde (4&#x00B0;C) for 24 h and fixed with 1&#x0025; osmotic acid-1.5&#x0025; potassium ferrocyanide for 1.5 h at room temperature. An alcohol gradient was used for dehydration: 75&#x0025; ethanol for 4 h, 85&#x0025; ethanol for 2 h, 90&#x0025; ethanol for 1 h, 100&#x0025; ethanol for 1 h and another 100&#x0025; ethanol for 1 h. Next, samples were immersed in 100&#x0025; xylene for 30 min and 100&#x0025; xylene for 1 h. Finally, samples were paraffin-embedded for 90 min. Ultrathin tissue sections were stained with 3&#x0025; uranyl acetate and lead citrate (50 nm) and the mitochondrial morphology was observed by TEM. The length/diameter ratio of the mitochondria was calculated and those with a ratio of &#x003E;2 were considered as long mitochondria (long-mito) (<xref rid="b16-mmr-25-05-12681" ref-type="bibr">16</xref>).</p>
</sec>
<sec>
<title>Cell culture</title>
<p>HT22 mouse hippocampus neuronal cells (Procell Life Science &#x0026; Technology Co., Ltd.) and N2a neuroblastoma cells (Wuhan Servicebio Technology Co., Ltd) were cultured in 10&#x0025; FBS high-glucose DMEM and MEM, respectively, with 1&#x0025; penicillin and streptomycin (complete medium) in a 5&#x0025; CO<sub>2</sub> incubator at 37&#x00B0;C.</p>
</sec>
<sec>
<title>Primary neuron extraction</title>
<p>Primary mouse neuron extraction was performed to investigate mitochondrial function. In brief, one pregnant (E15-17) C57 mouse which was purchased from the Animal Experiment Center of Tongji Medical College, Huazhong University of Science and Technology, was anesthetized using 10&#x0025; chloral hydrate (350 mg/kg) and the abdominal cavity was quickly opened and fetal mice (six mice) were removed. The pregnant and fetal mice were subsequently decapitated and the cortical regions were isolated and digested with 0.25&#x0025; trypsin (cat. no. G4001; Wuhan Servicebio Technology Co., Ltd.), followed by termination of digestion with medium (5&#x0025; FBS neurobasal medium; cat. no. H430717; Shanghai Basalmedia Technologies Co., Ltd.). After centrifugation, the cells were rapidly resuspended in medium. The prepared single cells were cultured in petri dishes coated with polylysine (Gibco; Thermo Fisher Scientific, Inc.). After 12 h of culture, the cells were placed in 1&#x0025; B27 (FBS-free) medium for subsequent experiments. The experimental protocol was reviewed and approved by the Animal Research and Care Committee of Tongji Medical College, Huazhong University of Science and Technology [approval no. SYXK(E)2017-0012].</p>
</sec>
<sec>
<title>Transfections</title>
<p>The cells were transfected when they had grown to &#x007E;70&#x0025; confluency. For this, 2 &#x00B5;l transfection reagent, 2 &#x00B5;g of probe plasmid or 5 pM of specific small inhibitory (si)RNA were added to 100 &#x00B5;l of Opti-MEM and incubated for 5 min. Opti-MEM with transfection reagents was then added to Opti-MEM with plasmid or siRNA. After resting for 15 min, the mixed suspension was added to the cell culture medium. In addition, a negative control group remained untransfected. The medium was replaced 6 h after transfection, the cells were cultured for another 24 h and then used in the following experiments. The sequences of negative control siRNA (si-NC) and GRP75-specific siGRP75 were as follows: si-NC forward, 5&#x2032;-UUCUCCGAACGUGUCACGUTT-3&#x2032; and reverse, 5&#x2032;-ACGUGACACGUUCGGAGAATT-3&#x2032;; siGRP75 forward, 5-GCGUCUUUACCAAACUUAUTT-3&#x2032; and reverse, 5&#x2032;-AUAAGUUUGGUAAAGACGCTT-3&#x2032;.</p>
</sec>
<sec>
<title>Mitotracker staining</title>
<p>For mitotracker staining, MitoTracker<sup>&#x00AE;</sup> Deep Red FM kits were used. In brief, cells were stained in the dark using mitotracker (500 nM) for 15 min and then observed with a fluorescence confocal microscope. ImageJ software v.1.51j8 (NIH) was used for the quantification of fluorescence.</p>
</sec>
<sec>
<title>Cellular oxygen and glucose deprivation (OGD) model</title>
<p>The cells were cultured in 10&#x0025; FBS glucose-free DMEM at 37&#x00B0;C in an incubator with 91&#x0025; N<sub>2,</sub> 5&#x0025; CO<sub>2</sub> and 4&#x0025; O<sub>2</sub> as the OGD conditions for varying time periods. Control cells were cultured under normal cell culture conditions in 95&#x0025; air and 5&#x0025; CO<sub>2</sub>; N2a cells were cultured in MEM with 10&#x0025; FBS and 1&#x0025; penicillin-streptomycin, while HT22 cells were cultured in DMEM with 10&#x0025; FBS and 1&#x0025; penicillin-streptomycin. MKT077 was added to the medium at a final concentration of 5 &#x00B5;M with incubation for 8 h in a 37&#x00B0;C cell incubator.</p>
</sec>
<sec>
<title>Western blot analysis</title>
<p>The different groups of cells were lysed in RIPA buffer containing 1 mM PMSF and 1 mM phosphatase inhibitor cocktail and centrifuged at 14,000 &#x00D7; g for 12 min at 4&#x00B0;C. After determining the protein concentration of each lysate sample using the BCA kit, the lysates (30 &#x00B5;g/lane) were separated by SDS-PAGE on 10&#x2013;12&#x0025; gels and transferred onto PVDF membranes (cat. no. WGPVDF45; Wuhan Servicebio Technology Co., Ltd.). The membranes were incubated with 5&#x0025; dry skimmed milk in 0.1&#x0025; Tween-20 in Tris-buffered saline for 1 h at room temperature and probed at 4&#x00B0;C overnight with primary antibodies (1:1,000 dilution for all). Subsequently, the membranes were incubated with HRP-conjugated goat anti-rabbit IgG and (1:10,000 dilution) and HRP-goat anti-mouse IgG and visualized with the ECL kit using a Bio-Rad exposure system (Bio-Rad Gel Doc XR; Bio-Rad Laboratories, Inc.) and the Image Lab 5.1 software (Bio-Rad Laboratories, Inc.). Quantitative results were obtained by densitometric scanning using ImageJ v.1.51j8 software (NIH).</p>
</sec>
<sec>
<title>Fluorescent analysis of mitochondrial Ca<sup>2&#x002B;</sup></title>
<p>The levels of mitochondrial Ca<sup>2&#x002B;</sup> in N2a cells were determined after transfection with mitochondrial Ca<sup>2&#x002B;</sup> probe plasmids which had been used previously (<xref rid="b17-mmr-25-05-12681" ref-type="bibr">17</xref>). In each confocal dish, 5&#x00D7;10<sup>4</sup> N2a cells were cultured for 24 h. The calcium plasmid was transfected into N2a cells for 24 h using the cell transfection method described above. After washing the cells with pre-warmed PBS solution, they were examined under a laser confocal microscope (A1R; Nikon Corporation) using Nikon Imaging Software Elements Viewer 4.20 (Nikon Corporation). The mitochondrial Ca<sup>2&#x002B;</sup> levels were determined by measuring average intensity levels using ImageJ software 1.51j8 (NIH).</p>
</sec>
<sec>
<title>Measurement of ATP</title>
<p>The levels of intracellular ATP in individual groups of cells were measured using a specific kit (cat. no. S0026B; Beyotime Institute of Biotechnology) following the manufacturer&#x0027;s protocol. In brief, the same numbers of cells in each group were lysed on ice and centrifuged. The supernatants were collected for the measurement of ATP levels using a luminometer (Promega Corporation) and the levels of ATP were calculated using the standard curve.</p>
</sec>
<sec>
<title>Measurement of the mitochondrial membrane potential (MMP)</title>
<p>The MMP of each group of cells was measured using the specific kit (cat. no. C2006; Beyotime Institute of Biotechnology) following the manufacturer&#x0027;s protocol. In brief, after treatment, the different groups of cells were stained with JC-1 solution at 37&#x00B0;C for 20 min. After being washed, the cells were imaged under a Nikon confocal microscope (A1R; Nikon Corporation) and the red and green fluorescent intensity of 100 cells from 6 randomly selected fields were analyzed using ImageJ software v.1.51j8 (NIH).</p>
</sec>
<sec>
<title>Measurement of reactive oxygen species (ROS) levels</title>
<p>The levels of intracellular ROS were measured using a specific kit (cat. no. S0033; Beyotime Institute of Biotechnology) following the manufacturer&#x0027;s protocol. In brief, the dichloro-dihydro-fluorescein diacetate (DCFH-DA) probe was diluted to 10 mM with FBS-free DMEM. The different groups of cells were stained with 10 mM DCFH-DA in FBS-free DMEM. The fluorescent signals in each group of cells were imaged under a Nikon confocal microscope (A1R; Nikon Corporation) and the green, fluorescent intensity of &#x007E;100 cells from 10 randomly selected fields were measured using ImageJ software v.1.51j8 (NIH).</p>
</sec>
<sec>
<title>Statistical analysis</title>
<p>Data were analyzed by GraphPad Prism 5 software (GraphPad Software, Inc.) and are expressed as the mean &#x00B1; standard error of the mean. Statistical significance was assessed by one-way ANOVA followed by Tukey&#x0027;s post-hoc test. P&#x003C;0.05 was considered to indicate a statistically significant difference.</p>
</sec>
</sec>
</sec>
<sec sec-type="results">
<title>Results</title>
<sec>
<title/>
<sec>
<title>Mitochondrial fragmentation and dysfunction induced by ischemia in vivo</title>
<p>First, male C57BL/6 mice were subjected to MCAO as a classical <italic>in vivo</italic> model of ischemic stroke (<xref rid="b18-mmr-25-05-12681" ref-type="bibr">18</xref>). TTC staining indicated obvious infraction in the brain of MCAO model mice (<xref rid="f1-mmr-25-05-12681" ref-type="fig">Fig. 1A</xref>). Acute hypoxia significantly influenced mitochondrial function; hence, TEM was used to confirm the morphology changes of mitochondria in ischemic mouse brains. As indicated in <xref rid="f1-mmr-25-05-12681" ref-type="fig">Fig. 1B</xref>, swollen and fragmented mitochondria were apparent in the MCAO group and the cristae of mitochondria were broken and fractured. However, the morphology of mitochondria was normal in the sham mice. Since mitochondrial function is tightly associated with the morphology of mitochondria (<xref rid="b19-mmr-25-05-12681" ref-type="bibr">19</xref>), several indexes reflecting mitochondrial function, including ATP content, ROS production and the MMP were also determined and it was indicated that mitochondrial function was significantly impaired by OGD (<xref rid="f1-mmr-25-05-12681" ref-type="fig">Figs. 1C</xref>, <xref rid="SD1-mmr-25-05-12681" ref-type="supplementary-material">S1</xref> and <xref rid="SD1-mmr-25-05-12681" ref-type="supplementary-material">S2</xref>).</p>
</sec>
<sec>
<title>Mitochondrial fragmentation and dysfunction induced by OGD in vitro</title>
<p>In order to further confirm the above results in an <italic>in vitro</italic> model, OGD was implemented to resemble the effects of MCAO in the HT22 and N2a cell lines. After 8 h of OGD, cellular mitochondria were observed by mitotracker staining (<xref rid="f2-mmr-25-05-12681" ref-type="fig">Fig. 2A</xref>). The mitochondria became fragmented after OGD, as the length of mitochondria decreased while the number of mitochondria per cell increased after OGD, which led to a decreased mitochondrial ratio. Similarly, OGD also impeded mitochondrial function (<xref rid="f2-mmr-25-05-12681" ref-type="fig">Fig. 2B</xref>) and decreased the MMP and ATP levels but increased ROS levels. In N2a cells, western blot analysis was used to detect mitochondrial dynamic-related proteins. The results indicated that under OGD conditions, mitochondrial fusion proteins MFN1 and MFN2 were downregulated, while mitochondrial fission proteins MFF and p-DRP1 increased significantly, indicating that the mitochondria became fragmented (<xref rid="f2-mmr-25-05-12681" ref-type="fig">Fig. 2C</xref>).</p>
</sec>
<sec>
<title>Mitochondrial calcium overload induced by OGD</title>
<p>GRP75 acts as a bridge, linking the ER-anchored inositol 1,4,5-trisphosphate receptor type 1 (IP3R) and mitochondria-located voltage-dependent anion-selective channel protein (VDAC) to form a protein complex and induce calcium transfer between ER and mitochondria (<xref rid="b13-mmr-25-05-12681" ref-type="bibr">13</xref>). In the present study, a mitochondrial tagged calcium sensor vector was used to monitor calcium levels in mitochondria and it was indicated that mitochondrial calcium levels were significantly elevated after OGD (<xref rid="f3-mmr-25-05-12681" ref-type="fig">Fig. 3A</xref>). It was then examined whether mitochondrial overload was related to abnormal GRP75 expression. Consistent with the present hypothesis, GRP75 was significantly elevated after OGD (<xref rid="f3-mmr-25-05-12681" ref-type="fig">Fig. 3B and C</xref>). This indicated that GRP75 may be related to OGD-induced mitochondrial calcium overload. The expression of GRP75 in the infarction area of the MCAO model was also examined, suggesting that GRP75 was also elevated <italic>in vivo</italic> (<xref rid="f3-mmr-25-05-12681" ref-type="fig">Fig. 3D</xref>). HIF1&#x03B1; is one of the most important modulators of hypoxia and the expression of HIF1&#x03B1; was thus determined; the results indicated that HIF1&#x03B1; was upregulated (<xref rid="f3-mmr-25-05-12681" ref-type="fig">Fig. 3E</xref>). Therefore, it may be hypothesized that the increase of HIF1&#x03B1; induced the upregulation of GRP75.</p>
</sec>
<sec>
<title>Inhibition of GRP75 by pharmacological agent preserves mitochondrial morphology and function under OGD</title>
<p>After confirming abnormal elevation of GRP75 after OGD, it was investigated whether interfering with GRP75 is an effective strategy to protect mitochondrial function after OGD. MKT077, a GRP75-specific inhibitor (<xref rid="b20-mmr-25-05-12681" ref-type="bibr">20</xref>), which is able to bind to GRP75 and abrogate its activity (<xref rid="b21-mmr-25-05-12681" ref-type="bibr">21</xref>), was applied and it was observed that, although MKT077 did not downregulate GRP75 expression after OGD (<xref rid="f4-mmr-25-05-12681" ref-type="fig">Fig. 4A</xref>), mitochondrial calcium overload was obviously inhibited after MKT077 treatment (<xref rid="f4-mmr-25-05-12681" ref-type="fig">Fig. 4B</xref>), which indicated that inhibiting GRP75 function prevented mitochondrial calcium overload. As expected, mitochondrial morphology was well-preserved by MKT077 even after OGD (<xref rid="f4-mmr-25-05-12681" ref-type="fig">Fig. 4C</xref>). This further supported the notion that mitochondrial calcium overload was able to trigger mitochondrial fragmentation and induce mitochondrial dysfunction (<xref rid="f4-mmr-25-05-12681" ref-type="fig">Figs. 4D</xref>, <xref rid="SD1-mmr-25-05-12681" ref-type="supplementary-material">S1</xref> and <xref rid="SD1-mmr-25-05-12681" ref-type="supplementary-material">S2</xref>).</p>
</sec>
<sec>
<title>Knockdown of GRP75 preserves mitochondrial morphology and function under OGD</title>
<p>In order to exclude any possible off-target effects of the small molecule antagonist, siRNA targeting at GRP75 was used to further confirm its effect on mitochondrial overload. siGRP75 efficiently reduced GRP75 expression levels after OGD, while si-NC did not influence the expression of GRP75 (<xref rid="f5-mmr-25-05-12681" ref-type="fig">Figs. 5A</xref> and <xref rid="SD1-mmr-25-05-12681" ref-type="supplementary-material">S3</xref>). Similar to the effect of MKT077, siGRP75 was also able to reduce mitochondrial calcium overload (<xref rid="f5-mmr-25-05-12681" ref-type="fig">Fig. 5B</xref>) and preserve mitochondrial morphology and function after OGD (<xref rid="f5-mmr-25-05-12681" ref-type="fig">Figs. 5C and D</xref>, <xref rid="SD1-mmr-25-05-12681" ref-type="supplementary-material">S1</xref> and <xref rid="SD1-mmr-25-05-12681" ref-type="supplementary-material">S2</xref>), which further confirmed that inhibiting GRP75 preserved mitochondrial morphology and function.</p>
</sec>
</sec>
</sec>
<sec sec-type="discussion">
<title>Discussion</title>
<p>As mitochondria are the major energy-producing organelles, their normal function is vital to cell survival, particularly to cells with high energy demand, such as neurons or cardiomyocytes (<xref rid="b22-mmr-25-05-12681" ref-type="bibr">22</xref>). In the present study, it was indicated that mitochondrial dysfunction took place both <italic>in vivo</italic> and <italic>in vitro</italic> under hypoxia stress. GRP75 was significantly upregulated by MCAO <italic>in vivo</italic> or OGD <italic>in vitro</italic>, and by inhibiting GRP75 via antagonist or siRNA, it was further confirmed that GRP75 was key to mitochondrial overload triggered by hypoxia. The present study supports the idea that GRP75 may be a promising target in treating ischemic stroke in future research.</p>
<p>Ischemic stroke affects the quality of life of patients. Neurons are vulnerable to lack of oxygen (<xref rid="b23-mmr-25-05-12681" ref-type="bibr">23</xref>), which may cause dysfunction of mitochondria, the power factory of the cell, leading to various neuronal disturbances. Qadri <italic>et al</italic> (<xref rid="b24-mmr-25-05-12681" ref-type="bibr">24</xref>) reported that mitochondrial dysfunction was one of the important causes of Parkinson&#x0027;s disease. Zhao <italic>et al</italic> (<xref rid="b25-mmr-25-05-12681" ref-type="bibr">25</xref>) indicated that after MCAO treatment, the expression of mitochondrial fission protein increased while the expression of mitochondrial fusion protein decreased, indicating that mitochondrial fragmentation occurred in the MCAO model, resulting in mitochondrial dysfunction and affecting the activity of neurons. Therefore, it is essential to maintain normal function of mitochondria to protect neurons.</p>
<p>GRP75 belongs to the mammalian HSP70 family, which is highly conserved and has various cellular functions, including cell survival (<xref rid="b26-mmr-25-05-12681" ref-type="bibr">26</xref>), the cell cycle and apoptosis (<xref rid="b27-mmr-25-05-12681" ref-type="bibr">27</xref>). It can help maintain intracellular homeostasis under various stresses, including hypoxia (<xref rid="b28-mmr-25-05-12681" ref-type="bibr">28</xref>). However, GRP75 has another important cellular function as a &#x2018;molecular bridge&#x2019; between IP3R and VDAC to form a calcium channel between the ER and mitochondrion. Although calcium is required by normal mitochondrial oxidative phosphorylation, excessive calcium disturbs this process and trigger more ROS production (<xref rid="b29-mmr-25-05-12681" ref-type="bibr">29</xref>). Calcium overload is thought to be an important pathological process during several ischemic diseases such as stroke and myocardial infarction, under which circumstances excessive calcium floods into the mitochondrion through different calcium channels, leading to mitochondrial dysfunction (<xref rid="b30-mmr-25-05-12681" ref-type="bibr">30</xref>). In the present study, it was indicated that under the conditions of OGD, the expression of GRP75 in neurons increased significantly and the mitochondria appeared to have calcium overload. This indicates that calcium flooded into the mitochondria. GRP75 is an important component in the OGD model, resulting in mitochondrial calcium overload and mitochondrial damage. Furthermore, evidence was provided that inhibiting GRP75 via MKT077 or direct knockdown of GRP75 alleviated OGD induced mitochondrial calcium overload and preserved cell viability. However, as a member of the HSP family, GRP75 also has various physiological functions, such as iron-sulfur cluster assembly, protein refolding (<xref rid="b31-mmr-25-05-12681" ref-type="bibr">31</xref>) and erythrocyte differentiation (<xref rid="b32-mmr-25-05-12681" ref-type="bibr">32</xref>). Considering such important physiological functions of GRP75, how to titer optimized dosage of GRP75 inhibition under different stress conditions may be a challenge and this is the obvious weakness of inhibiting GRP75 and requires further investigation. In conclusion, GRP75 may be a promising target but requires further investigation.</p>
<p>MKT-077 is a rhodacyanine dye and also an HSP70 inhibitor, which exhibits significant antitumor activity (<xref rid="b33-mmr-25-05-12681" ref-type="bibr">33</xref>). A previous study by our group indicated that MKT077 did not reduce the expression of GRP75 but inhibited the GRP75-mediated ER-mitochondrial calcium exchange (<xref rid="b16-mmr-25-05-12681" ref-type="bibr">16</xref>). Miyata <italic>et al</italic> (<xref rid="b34-mmr-25-05-12681" ref-type="bibr">34</xref>) reported that a derivative of MKT077 had blood-brain-barrier permeability properties and reduced Tau levels in the brain. Thus, further studies by our group will use YM-08 (a derivative of MKT077) for intragastric administration of mice to observe its therapeutic effect. This noteworthy pharmacological evolution of MKT077 provided evidence that GRP75 was able to regulate cellular processes more than maintaining calcium homeostasis. However, concerns about off-target effects of small-molecule antagonists led us to use siRNA to more precisely interfere with GRP75 and the results further confirmed the function of GRP75 in the pathophysiological process of ischemic stroke.</p>
<p>However, there are several limitations of the present study. Mitochondrial function may only be roughly evaluated via the MMP, as well as ROS and ATP production. Furthermore, mitochondrial calcium was only determined in N2a cells, while it was not possible to measure calcium ions in the mitochondria of HT22 cells due to issues with the transfection of the calcium probe plasmid. In addition, the mechanism by which ischemic stress increases GRP75 expression remains elusive. Under hypoxia circumstances, HIF1&#x03B1; is rapidly upregulated and is able to regulate the expression of various genes. It was reported that HIF1&#x03B1; was able to regulate the expression of GRP75 (<xref rid="b35-mmr-25-05-12681" ref-type="bibr">35</xref>); hence, it may be the mechanism of GRP75 upregulation by MCAO or OGD in the present study.</p>
<p>In conclusion, the present study provided evidence that GRP75 is an important factor in hypoxia-induced neuron injury both <italic>in vivo</italic> and <italic>in vitro</italic>. GRP75 was able to augment mitochondria-associated endoplasmic reticulum membranes formation and lead to mitochondrial calcium overload, ultimately leading to mitochondrial dysfunction and disruption of energy supply to neurons, making neurons vulnerable to hypoxia (<xref rid="f6-mmr-25-05-12681" ref-type="fig">Fig. 6</xref>). Inhibiting GRP75 may be a promising strategy to ameliorate injury following ischemic stroke in future research.</p>
</sec>
<sec sec-type="supplementary-material">
<title>Supplementary Material</title>
<supplementary-material id="SD1-mmr-25-05-12681" content-type="local-data">
<caption>
<title>Supporting Data</title>
</caption>
<media mimetype="application" mime-subtype="pdf" xlink:href="Supplementary_Data.pdf"/>
</supplementary-material>
</sec>
</body>
<back>
<ack>
<title>Acknowledgements</title>
<p>Not applicable.</p>
</ack>
<sec sec-type="data-availability">
<title>Availability of data and materials</title>
<p>The raw data and materials generated and used during this study are available from the corresponding author upon reasonable request.</p>
</sec>
<sec>
<title>Author&#x0027;s contributions</title>
<p>BW drafted the manuscript. BW and KX established the cell culture and animal model. JiC and RH performed the western blotting analysis and confocal microscopy. TJ and JW performed biochemical measurements. BH and JuC participated in the design and preparation of the manuscript, as well as conceived the study and participated in the coordination and preparation of the manuscript. All authors read and approved the final version of the manuscript and confirmed the authenticity of the raw data.</p>
</sec>
<sec>
<title>Ethics approval and consent to participate</title>
<p>The animal experiments were approved by the Animal Care and Use Committee at the Huazhong University of Science and Technology (Wuhan, China).</p>
</sec>
<sec>
<title>Patient consent for publication</title>
<p>Not applicable.</p>
</sec>
<sec sec-type="COI-statement">
<title>Competing interests</title>
<p>The authors declare that they have no competing interests.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="b1-mmr-25-05-12681"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paul</surname><given-names>S</given-names></name><name><surname>Candelario-Jalil</surname><given-names>E</given-names></name></person-group><article-title>Emerging neuroprotective strategies for the treatment of ischemic stroke: An overview of clinical and preclinical studies</article-title><source>Exp Neurol</source><volume>335</volume><fpage>113518</fpage><year>2021</year><pub-id pub-id-type="doi">10.1016/j.expneurol.2020.113518</pub-id><pub-id pub-id-type="pmid">33144066</pub-id></element-citation></ref>
<ref id="b2-mmr-25-05-12681"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Su</surname><given-names>XT</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Ma</surname><given-names>SM</given-names></name><name><surname>Cao</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>NN</given-names></name><name><surname>Lin</surname><given-names>LL</given-names></name><name><surname>Fisher</surname><given-names>M</given-names></name><name><surname>Yang</surname><given-names>JW</given-names></name><name><surname>Liu</surname><given-names>CZ</given-names></name></person-group><article-title>Mechanisms of acupuncture in the regulation of oxidative stress in treating ischemic stroke</article-title><source>Oxid Med Cell Longev</source><month>Oct</month><day>24</day><year>2020</year><comment>(Epub ahead of print)</comment><pub-id pub-id-type="doi">10.1155/2020/7875396</pub-id></element-citation></ref>
<ref id="b3-mmr-25-05-12681"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ranjbar Taklimie</surname><given-names>F</given-names></name><name><surname>Gasterich</surname><given-names>N</given-names></name><name><surname>Scheld</surname><given-names>M</given-names></name><name><surname>Weiskirchen</surname><given-names>R</given-names></name><name><surname>Beyer</surname><given-names>C</given-names></name><name><surname>Clarner</surname><given-names>T</given-names></name><name><surname>Zendedel</surname><given-names>A</given-names></name></person-group><article-title>Hypoxia induces astrocyte-derived Lipocalin-2 in ischemic stroke</article-title><source>Int J Mol Sci</source><volume>20</volume><fpage>1271</fpage><year>2019</year><pub-id pub-id-type="doi">10.3390/ijms20061271</pub-id><pub-id pub-id-type="pmid">30871254</pub-id></element-citation></ref>
<ref id="b4-mmr-25-05-12681"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lv</surname><given-names>J</given-names></name><name><surname>Guan</surname><given-names>W</given-names></name><name><surname>You</surname><given-names>Q</given-names></name><name><surname>Deng</surname><given-names>L</given-names></name><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>Guo</surname><given-names>K</given-names></name><name><surname>Gao</surname><given-names>X</given-names></name><name><surname>Kong</surname><given-names>J</given-names></name><name><surname>Yang</surname><given-names>C</given-names></name></person-group><article-title>RIPC provides neuroprotection against ischemic stroke by suppressing apoptosis via the mitochondrial pathway</article-title><source>Sci Rep</source><volume>10</volume><fpage>5361</fpage><year>2020</year><pub-id pub-id-type="doi">10.1038/s41598-020-62336-w</pub-id><pub-id pub-id-type="pmid">32210331</pub-id></element-citation></ref>
<ref id="b5-mmr-25-05-12681"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>CL</given-names></name><name><surname>Hou</surname><given-names>GG</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Ru</surname><given-names>T</given-names></name><name><surname>Xu</surname><given-names>YZ</given-names></name><name><surname>Zhao</surname><given-names>SY</given-names></name><name><surname>Ye</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>LY</given-names></name><name><surname>Chen</surname><given-names>KX</given-names></name><name><surname>Guo</surname><given-names>YW</given-names></name><etal/></person-group><article-title>Synthesis and target identification of benzoxepane derivatives as potential anti-neuroinflammatory agents for ischemic stroke</article-title><source>Angew Chem Int Ed Engl</source><volume>59</volume><fpage>2429</fpage><lpage>2439</lpage><year>2020</year><pub-id pub-id-type="doi">10.1002/anie.201912489</pub-id><pub-id pub-id-type="pmid">31782597</pub-id></element-citation></ref>
<ref id="b6-mmr-25-05-12681"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alim</surname><given-names>I</given-names></name><name><surname>Caulfield</surname><given-names>JT</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Swarup</surname><given-names>V</given-names></name><name><surname>Geschwind</surname><given-names>DH</given-names></name><name><surname>Ivanova</surname><given-names>E</given-names></name><name><surname>Seravalli</surname><given-names>J</given-names></name><name><surname>Ai</surname><given-names>Y</given-names></name><name><surname>Sansing</surname><given-names>LH</given-names></name><name><surname>Ste Marie</surname><given-names>EJ</given-names></name><etal/></person-group><article-title>Selenium drives a transcriptional adaptive program to block ferroptosis and treat stroke</article-title><source>Cell</source><volume>177</volume><fpage>1262</fpage><lpage>1279.e1225</lpage><year>2019</year><pub-id pub-id-type="doi">10.1016/j.cell.2019.03.032</pub-id><pub-id pub-id-type="pmid">31056284</pub-id></element-citation></ref>
<ref id="b7-mmr-25-05-12681"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guadagno</surname><given-names>JV</given-names></name><name><surname>Jones</surname><given-names>PS</given-names></name><name><surname>Fryer</surname><given-names>TD</given-names></name><name><surname>Barret</surname><given-names>O</given-names></name><name><surname>Aigbirhio</surname><given-names>FI</given-names></name><name><surname>Carpenter</surname><given-names>TA</given-names></name><name><surname>Price</surname><given-names>CJ</given-names></name><name><surname>Gillard</surname><given-names>JH</given-names></name><name><surname>Warburton</surname><given-names>EA</given-names></name><name><surname>Baron</surname><given-names>JC</given-names></name></person-group><article-title>Local relationships between restricted water diffusion and oxygen consumption in the ischemic human brain</article-title><source>Stroke</source><volume>37</volume><fpage>1741</fpage><lpage>1748</lpage><year>2006</year><pub-id pub-id-type="doi">10.1161/01.STR.0000232437.00621.86</pub-id><pub-id pub-id-type="pmid">16763173</pub-id></element-citation></ref>
<ref id="b8-mmr-25-05-12681"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Sun</surname><given-names>H</given-names></name><name><surname>Xu</surname><given-names>G</given-names></name><name><surname>McCarter</surname><given-names>KD</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Mayhan</surname><given-names>WG</given-names></name></person-group><article-title>Mito-tempo prevents nicotine-induced exacerbation of ischemic brain damage</article-title><source>J Appl Physiol (1985)</source><volume>125</volume><fpage>49</fpage><lpage>57</lpage><year>2018</year><pub-id pub-id-type="doi">10.1152/japplphysiol.01084.2017</pub-id><pub-id pub-id-type="pmid">29420160</pub-id></element-citation></ref>
<ref id="b9-mmr-25-05-12681"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rose</surname><given-names>J</given-names></name><name><surname>Brian</surname><given-names>C</given-names></name><name><surname>Woods</surname><given-names>J</given-names></name><name><surname>Pappa</surname><given-names>A</given-names></name><name><surname>Panayiotidis</surname><given-names>MI</given-names></name><name><surname>Powers</surname><given-names>R</given-names></name><name><surname>Franco</surname><given-names>R</given-names></name></person-group><article-title>Mitochondrial dysfunction in glial cells: Implications for neuronal homeostasis and survival</article-title><source>Toxicology</source><volume>391</volume><fpage>109</fpage><lpage>115</lpage><year>2017</year><pub-id pub-id-type="doi">10.1016/j.tox.2017.06.011</pub-id><pub-id pub-id-type="pmid">28655545</pub-id></element-citation></ref>
<ref id="b10-mmr-25-05-12681"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mondal</surname><given-names>NK</given-names></name><name><surname>Behera</surname><given-names>J</given-names></name><name><surname>Kelly</surname><given-names>KE</given-names></name><name><surname>George</surname><given-names>AK</given-names></name><name><surname>Tyagi</surname><given-names>PK</given-names></name><name><surname>Tyagi</surname><given-names>N</given-names></name></person-group><article-title>Tetrahydrocurcumin epigenetically mitigates mitochondrial dysfunction in brain vasculature during ischemic stroke</article-title><source>Neurochem Int</source><volume>122</volume><fpage>120</fpage><lpage>138</lpage><year>2019</year><pub-id pub-id-type="doi">10.1016/j.neuint.2018.11.015</pub-id><pub-id pub-id-type="pmid">30472160</pub-id></element-citation></ref>
<ref id="b11-mmr-25-05-12681"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>D</given-names></name><name><surname>Sun</surname><given-names>Y</given-names></name><name><surname>Tan</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Hou</surname><given-names>Z</given-names></name><name><surname>Gao</surname><given-names>C</given-names></name><name><surname>Feng</surname><given-names>P</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Yi</surname><given-names>W</given-names></name><name><surname>Gao</surname><given-names>F</given-names></name></person-group><article-title>Short-duration swimming exercise after myocardial infarction attenuates cardiac dysfunction and regulates mitochondrial quality control in aged mice</article-title><source>Oxid Med Cell Longev</source><volume>2018</volume><fpage>4079041</fpage><year>2018</year><pub-id pub-id-type="doi">10.1155/2018/4079041</pub-id><pub-id pub-id-type="pmid">29849892</pub-id></element-citation></ref>
<ref id="b12-mmr-25-05-12681"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galvan</surname><given-names>DL</given-names></name><name><surname>Green</surname><given-names>NH</given-names></name><name><surname>Danesh</surname><given-names>FR</given-names></name></person-group><article-title>The hallmarks of mitochondrial dysfunction in chronic kidney disease</article-title><source>Kidney Int</source><volume>92</volume><fpage>1051</fpage><lpage>1057</lpage><year>2017</year><pub-id pub-id-type="doi">10.1016/j.kint.2017.05.034</pub-id><pub-id pub-id-type="pmid">28893420</pub-id></element-citation></ref>
<ref id="b13-mmr-25-05-12681"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thoudam</surname><given-names>T</given-names></name><name><surname>Ha</surname><given-names>CM</given-names></name><name><surname>Leem</surname><given-names>J</given-names></name><name><surname>Chanda</surname><given-names>D</given-names></name><name><surname>Park</surname><given-names>JS</given-names></name><name><surname>Kim</surname><given-names>HJ</given-names></name><name><surname>Jeon</surname><given-names>JH</given-names></name><name><surname>Choi</surname><given-names>YK</given-names></name><name><surname>Liangpunsakul</surname><given-names>S</given-names></name><name><surname>Huh</surname><given-names>YH</given-names></name><etal/></person-group><article-title>PDK4 augments ER-mitochondria contact to dampen skeletal muscle insulin signaling during obesity</article-title><source>Diabetes</source><volume>68</volume><fpage>571</fpage><lpage>586</lpage><year>2019</year><pub-id pub-id-type="doi">10.2337/db18-0363</pub-id><pub-id pub-id-type="pmid">30523025</pub-id></element-citation></ref>
<ref id="b14-mmr-25-05-12681"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>J</given-names></name><name><surname>Dai</surname><given-names>J</given-names></name><name><surname>Cui</surname><given-names>H</given-names></name></person-group><article-title>Vitexin reverses the autophagy dysfunction to attenuate MCAO-induced cerebral ischemic stroke via mTOR/Ulk1 pathway</article-title><source>Biomed Pharmacother</source><volume>99</volume><fpage>583</fpage><lpage>590</lpage><year>2018</year><pub-id pub-id-type="doi">10.1016/j.biopha.2018.01.067</pub-id><pub-id pub-id-type="pmid">29710456</pub-id></element-citation></ref>
<ref id="b15-mmr-25-05-12681"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>HK</given-names></name><name><surname>Russell</surname><given-names>JM</given-names></name><name><surname>Granger</surname><given-names>DN</given-names></name><name><surname>Gavins</surname><given-names>FN</given-names></name></person-group><article-title>Critical differences between two classical surgical approaches for middle cerebral artery occlusion-induced stroke in mice</article-title><source>J Neurosci Methods</source><volume>249</volume><fpage>99</fpage><lpage>105</lpage><year>2015</year><pub-id pub-id-type="doi">10.1016/j.jneumeth.2015.04.008</pub-id><pub-id pub-id-type="pmid">25936850</pub-id></element-citation></ref>
<ref id="b16-mmr-25-05-12681"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Bai</surname><given-names>J</given-names></name><name><surname>Tian</surname><given-names>X</given-names></name><name><surname>Zhao</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>W</given-names></name><name><surname>Duan</surname><given-names>X</given-names></name><name><surname>Shang</surname><given-names>W</given-names></name><name><surname>Fan</surname><given-names>HY</given-names></name><name><surname>Tong</surname><given-names>C</given-names></name></person-group><article-title>Mitoguardin regulates mitochondrial fusion through MitoPLD and is required for neuronal homeostasis</article-title><source>Mol Cell</source><volume>61</volume><fpage>111</fpage><lpage>124</lpage><year>2016</year><pub-id pub-id-type="doi">10.1016/j.molcel.2015.11.017</pub-id><pub-id pub-id-type="pmid">26711011</pub-id></element-citation></ref>
<ref id="b17-mmr-25-05-12681"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liang</surname><given-names>T</given-names></name><name><surname>Hang</surname><given-names>W</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Wen</surname><given-names>B</given-names></name><name><surname>Xu</surname><given-names>K</given-names></name><name><surname>Ding</surname><given-names>B</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name></person-group><article-title>ApoE4 (&#x0394;272-299) induces mitochondrial-associated membrane formation and mitochondrial impairment by enhancing GRP75-modulated mitochondrial calcium overload in neuron</article-title><source>Cell Biosci</source><volume>11</volume><fpage>50</fpage><year>2021</year><pub-id pub-id-type="doi">10.1186/s13578-021-00563-y</pub-id><pub-id pub-id-type="pmid">33676568</pub-id></element-citation></ref>
<ref id="b18-mmr-25-05-12681"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knauss</surname><given-names>S</given-names></name><name><surname>Albrecht</surname><given-names>C</given-names></name><name><surname>Dirnagl</surname><given-names>U</given-names></name><name><surname>Mueller</surname><given-names>S</given-names></name><name><surname>Harms</surname><given-names>C</given-names></name><name><surname>Hoffmann</surname><given-names>CJ</given-names></name><name><surname>Koch</surname><given-names>SP</given-names></name><name><surname>Endres</surname><given-names>M</given-names></name><name><surname>Boehm-Sturm</surname><given-names>P</given-names></name></person-group><article-title>A semiquantitative non-invasive measurement of PcomA patency in C57BL/6 mice explains variance in ischemic brain damage in filament MCAO</article-title><source>Front Neurosci</source><volume>14</volume><fpage>576741</fpage><year>2020</year><pub-id pub-id-type="doi">10.3389/fnins.2020.576741</pub-id><pub-id pub-id-type="pmid">33071747</pub-id></element-citation></ref>
<ref id="b19-mmr-25-05-12681"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seo</surname><given-names>SJ</given-names></name><name><surname>Yoon</surname><given-names>SH</given-names></name><name><surname>Do</surname><given-names>JT</given-names></name></person-group><article-title>Mitochondrial dynamics in stem cells and differentiation</article-title><source>Int J Mol Sci</source><volume>19</volume><fpage>3893</fpage><year>2018</year><pub-id pub-id-type="doi">10.3390/ijms19123893</pub-id><pub-id pub-id-type="pmid">30563106</pub-id></element-citation></ref>
<ref id="b20-mmr-25-05-12681"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>PK</given-names></name><name><surname>Hong</surname><given-names>SK</given-names></name><name><surname>Starenki</surname><given-names>D</given-names></name><name><surname>Oshima</surname><given-names>K</given-names></name><name><surname>Shao</surname><given-names>H</given-names></name><name><surname>Gestwicki</surname><given-names>JE</given-names></name><name><surname>Tsai</surname><given-names>S</given-names></name><name><surname>Park</surname><given-names>JI</given-names></name></person-group><article-title>Mortalin/HSPA9 targeting selectively induces KRAS tumor cell death by perturbing mitochondrial membrane permeability</article-title><source>Oncogene</source><volume>39</volume><fpage>4257</fpage><lpage>4270</lpage><year>2020</year><pub-id pub-id-type="doi">10.1038/s41388-020-1285-5</pub-id><pub-id pub-id-type="pmid">32291414</pub-id></element-citation></ref>
<ref id="b21-mmr-25-05-12681"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rousaki</surname><given-names>A</given-names></name><name><surname>Miyata</surname><given-names>Y</given-names></name><name><surname>Jinwal</surname><given-names>UK</given-names></name><name><surname>Dickey</surname><given-names>CA</given-names></name><name><surname>Gestwicki</surname><given-names>JE</given-names></name><name><surname>Zuiderweg</surname><given-names>ER</given-names></name></person-group><article-title>Allosteric drugs: The interaction of antitumor compound MKT-077 with human Hsp70 chaperones</article-title><source>J Mol Biol</source><volume>411</volume><fpage>614</fpage><lpage>632</lpage><year>2011</year><pub-id pub-id-type="doi">10.1016/j.jmb.2011.06.003</pub-id><pub-id pub-id-type="pmid">21708173</pub-id></element-citation></ref>
<ref id="b22-mmr-25-05-12681"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Escobar-Henriques</surname><given-names>M</given-names></name><name><surname>Joaquim</surname><given-names>M</given-names></name></person-group><article-title>Mitofusins: Disease gatekeepers and hubs in mitochondrial quality control by E3 Ligases</article-title><source>Front Physiol</source><volume>10</volume><fpage>517</fpage><year>2019</year><pub-id pub-id-type="doi">10.3389/fphys.2019.00517</pub-id><pub-id pub-id-type="pmid">31156446</pub-id></element-citation></ref>
<ref id="b23-mmr-25-05-12681"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Head</surname><given-names>E</given-names></name><name><surname>Rofina</surname><given-names>J</given-names></name><name><surname>Zicker</surname><given-names>S</given-names></name></person-group><article-title>Oxidative stress, aging, and central nervous system disease in the canine model of human brain aging</article-title><source>Vet Clin North Am Small Anim Pract</source><volume>38</volume><fpage>167</fpage><lpage>178</lpage><year>2008</year><pub-id pub-id-type="doi">10.1016/j.cvsm.2007.10.002</pub-id><pub-id pub-id-type="pmid">18249248</pub-id></element-citation></ref>
<ref id="b24-mmr-25-05-12681"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qadri</surname><given-names>R</given-names></name><name><surname>Goyal</surname><given-names>V</given-names></name><name><surname>Behari</surname><given-names>M</given-names></name><name><surname>Subramanian</surname><given-names>A</given-names></name><name><surname>Datta</surname><given-names>SK</given-names></name><name><surname>Mukhopadhyay</surname><given-names>AK</given-names></name></person-group><article-title>Alteration of mitochondrial function in oxidative stress in parkinsonian neurodegeneration: A cross-sectional study</article-title><source>Ann Indian Acad Neurol</source><volume>24</volume><fpage>506</fpage><lpage>512</lpage><year>2021</year><pub-id pub-id-type="pmid">34728942</pub-id></element-citation></ref>
<ref id="b25-mmr-25-05-12681"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>J</given-names></name><name><surname>Dong</surname><given-names>L</given-names></name><name><surname>Huo</surname><given-names>T</given-names></name><name><surname>Cheng</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Huangfu</surname><given-names>X</given-names></name><name><surname>Sun</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>L</given-names></name></person-group><article-title>O-GlcNAc Transferase (OGT) protects cerebral neurons from death during Ischemia/Reperfusion (I/R) injury by modulating Drp1 in mice</article-title><source>Neuromolecular Med</source><month>Oct</month><day>27</day><year>2021</year><comment>(Epub ahead of print)</comment><pub-id pub-id-type="doi">10.1007/s12017-021-08688-6</pub-id></element-citation></ref>
<ref id="b26-mmr-25-05-12681"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Starenki</surname><given-names>D</given-names></name><name><surname>Sosonkina</surname><given-names>N</given-names></name><name><surname>Hong</surname><given-names>SK</given-names></name><name><surname>Lloyd</surname><given-names>RV</given-names></name><name><surname>Park</surname><given-names>JI</given-names></name></person-group><article-title>Mortalin (GRP75/HSPA9) promotes survival and proliferation of thyroid carcinoma cells</article-title><source>Int J Mol Sci</source><volume>20</volume><fpage>2069</fpage><year>2019</year><pub-id pub-id-type="doi">10.3390/ijms20092069</pub-id><pub-id pub-id-type="pmid">31027376</pub-id></element-citation></ref>
<ref id="b27-mmr-25-05-12681"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>G</given-names></name><name><surname>Han</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Xiao</surname><given-names>A</given-names></name></person-group><article-title>GRP75 involves in retinal ganglion cell apoptosis after rat optic nerve crush</article-title><source>J Mol Neurosci</source><volume>56</volume><fpage>422</fpage><lpage>430</lpage><year>2015</year><pub-id pub-id-type="doi">10.1007/s12031-015-0493-x</pub-id><pub-id pub-id-type="pmid">25600835</pub-id></element-citation></ref>
<ref id="b28-mmr-25-05-12681"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D&#x0027;Eletto</surname><given-names>M</given-names></name><name><surname>Rossin</surname><given-names>F</given-names></name><name><surname>Occhigrossi</surname><given-names>L</given-names></name><name><surname>Farrace</surname><given-names>MG</given-names></name><name><surname>Faccenda</surname><given-names>D</given-names></name><name><surname>Desai</surname><given-names>R</given-names></name><name><surname>Marchi</surname><given-names>S</given-names></name><name><surname>Refolo</surname><given-names>G</given-names></name><name><surname>Falasca</surname><given-names>L</given-names></name><name><surname>Antonioli</surname><given-names>M</given-names></name><etal/></person-group><article-title>Piacentini, transglutaminase type 2 regulates ER-mitochondria contact sites by interacting with GRP75</article-title><source>Cell Rep</source><volume>25</volume><fpage>3573</fpage><lpage>3581</lpage><fpage>e3574</fpage><year>2018</year><pub-id pub-id-type="doi">10.1016/j.celrep.2018.11.094</pub-id><pub-id pub-id-type="pmid">30590033</pub-id></element-citation></ref>
<ref id="b29-mmr-25-05-12681"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brookes</surname><given-names>PS</given-names></name><name><surname>Yoon</surname><given-names>Y</given-names></name><name><surname>Robotham</surname><given-names>JL</given-names></name><name><surname>Anders</surname><given-names>MW</given-names></name><name><surname>Sheu</surname><given-names>SS</given-names></name></person-group><article-title>Calcium, ATP, and ROS: A mitochondrial love-hate triangle</article-title><source>Am J Physiol Cell Physiol</source><volume>287</volume><fpage>C817</fpage><lpage>C833</lpage><year>2004</year><pub-id pub-id-type="doi">10.1152/ajpcell.00139.2004</pub-id><pub-id pub-id-type="pmid">15355853</pub-id></element-citation></ref>
<ref id="b30-mmr-25-05-12681"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verma</surname><given-names>M</given-names></name><name><surname>Wills</surname><given-names>Z</given-names></name><name><surname>Chu</surname><given-names>CT</given-names></name></person-group><article-title>Excitatory dendritic mitochondrial calcium toxicity: Implications for Parkinson&#x0027;s and other neurodegenerative diseases</article-title><source>Front Neurosci</source><volume>12</volume><fpage>523</fpage><year>2018</year><pub-id pub-id-type="doi">10.3389/fnins.2018.00523</pub-id><pub-id pub-id-type="pmid">30116173</pub-id></element-citation></ref>
<ref id="b31-mmr-25-05-12681"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shan</surname><given-names>Y</given-names></name><name><surname>Cortopassi</surname><given-names>G</given-names></name></person-group><article-title>Mitochondrial Hspa9/Mortalin regulates erythroid differentiation via iron-sulfur cluster assembly</article-title><source>Mitochondrion</source><volume>26</volume><fpage>94</fpage><lpage>103</lpage><year>2016</year><pub-id pub-id-type="doi">10.1016/j.mito.2015.12.005</pub-id><pub-id pub-id-type="pmid">26702583</pub-id></element-citation></ref>
<ref id="b32-mmr-25-05-12681"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>TH</given-names></name><name><surname>Kambal</surname><given-names>A</given-names></name><name><surname>Krysiak</surname><given-names>K</given-names></name><name><surname>Walshauser</surname><given-names>MA</given-names></name><name><surname>Raju</surname><given-names>G</given-names></name><name><surname>Tibbitts</surname><given-names>JF</given-names></name><name><surname>Walter</surname><given-names>MJ</given-names></name></person-group><article-title>Knockdown of Hspa9, a del(5q31.2) gene, results in a decrease in hematopoietic progenitors in mice</article-title><source>Blood</source><volume>117</volume><fpage>1530</fpage><lpage>1539</lpage><year>2011</year><pub-id pub-id-type="doi">10.1182/blood-2010-06-293167</pub-id><pub-id pub-id-type="pmid">21123823</pub-id></element-citation></ref>
<ref id="b33-mmr-25-05-12681"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Srinivasan</surname><given-names>SR</given-names></name><name><surname>Connarn</surname><given-names>J</given-names></name><name><surname>Ahmad</surname><given-names>A</given-names></name><name><surname>Young</surname><given-names>ZT</given-names></name><name><surname>Kabza</surname><given-names>AM</given-names></name><name><surname>Zuiderweg</surname><given-names>ER</given-names></name><name><surname>Sun</surname><given-names>D</given-names></name><name><surname>Gestwicki</surname><given-names>JE</given-names></name></person-group><article-title>Analogs of the allosteric heat shock protein 70 (Hsp70) inhibitor, MKT-077, as anti-cancer agents</article-title><source>ACS Med Chem Lett</source><volume>4</volume><fpage>1042</fpage><lpage>1047</lpage><year>2013</year><pub-id pub-id-type="doi">10.1021/ml400204n</pub-id><pub-id pub-id-type="pmid">24312699</pub-id></element-citation></ref>
<ref id="b34-mmr-25-05-12681"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyata</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Lee</surname><given-names>HF</given-names></name><name><surname>Jinwal</surname><given-names>UK</given-names></name><name><surname>Srinivasan</surname><given-names>SR</given-names></name><name><surname>Seguin</surname><given-names>SP</given-names></name><name><surname>Young</surname><given-names>ZT</given-names></name><name><surname>Brodsky</surname><given-names>JL</given-names></name><name><surname>Dickey</surname><given-names>CA</given-names></name><name><surname>Sun</surname><given-names>D</given-names></name><name><surname>Gestwicki</surname><given-names>JE</given-names></name></person-group><article-title>Synthesis and initial evaluation of YM-08, a blood-brain barrier permeable derivative of the heat shock protein 70 (Hsp70) inhibitor MKT-077, which reduces tau levels</article-title><source>ACS Chem Neurosci</source><volume>4</volume><fpage>930</fpage><lpage>939</lpage><year>2013</year><pub-id pub-id-type="doi">10.1021/cn300210g</pub-id><pub-id pub-id-type="pmid">23472668</pub-id></element-citation></ref>
<ref id="b35-mmr-25-05-12681"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mylonis</surname><given-names>I</given-names></name><name><surname>Kourti</surname><given-names>M</given-names></name><name><surname>Samiotaki</surname><given-names>M</given-names></name><name><surname>Panayotou</surname><given-names>G</given-names></name><name><surname>Simos</surname><given-names>G</given-names></name></person-group><article-title>Mortalin-mediated and ERK-controlled targeting of HIF-1&#x03B1; to mitochondria confers resistance to apoptosis under hypoxia</article-title><source>J Cell Sci</source><volume>130</volume><fpage>466</fpage><lpage>479</lpage><year>2017</year><pub-id pub-id-type="pmid">27909249</pub-id></element-citation></ref>
</ref-list>
</back>
<floats-group>
<fig id="f1-mmr-25-05-12681" position="float">
<label>Figure 1.</label>
<caption><p>Mitochondria fragmentation and dysfunction induced by ischemia <italic>in vivo</italic> and <italic>in vitro</italic>. (A) Infarct volumes of mouse brains from different groups of mice. (B) Electron microscopy analysis of damaged mitochondrial (arrows) in mouse brains. The number of long mitochondria per cell was determined (scale bars, 2 &#x00B5;m). (C) Primary neurons were cultured under different conditions <italic>in vitro</italic> and the relative ATP content (left panel), mitochondrial membrane potential (relative to red/green fluorescence, middle panel) and relative content of ROS (right panel) were determined. Representative images are provided and quantitative data are expressed as the mean &#x00B1; standard error of the mean of each group from three separate experiments. &#x002A;&#x002A;P&#x003C;0.01, &#x002A;&#x002A;&#x002A;&#x002A;P&#x003C;0.0001 vs. Ctrl. Ctrl, control; MCAO, middle cerebral artery occlusion; OGD, oxygen-glucose deprivation; long-mito, long mitochondria with a length/diameter ratio of &#x003E;2; ROS, reactive oxygen species.</p></caption>
<graphic xlink:href="mmr-25-05-12681-g00.tif"/>
</fig>
<fig id="f2-mmr-25-05-12681" position="float">
<label>Figure 2.</label>
<caption><p>Mitochondrial fragmentation and dysfunction induced by OGD <italic>in vitro</italic>. (A) Fluorescence imaging analysis of mitochondrial morphology of HT22 and N2a cells (scale bars, 5 &#x00B5;m). (B) Western blot analysis revealed mitochondrial dynamic protein expression in the N2a cells. (C) OGD impaired mitochondrial function in HT22 and N2a cells. Representative images are provided and quantitative results are expressed as the mean &#x00B1; standard error of the mean of each group from three separate experiments. &#x002A;&#x002A;P&#x003C;0.01, &#x002A;&#x002A;&#x002A;P&#x003C;0.001, &#x002A;&#x002A;&#x002A;&#x002A;P&#x003C;0.0001 vs. Ctrl. Ctrl, control; OGD, oxygen-glucose deprivation; MFN, mitofision protein; MFF, mitochondria fission factor; DRP1, dynamin-1 protein; p, phosphorylated.</p></caption>
<graphic xlink:href="mmr-25-05-12681-g01.tif"/>
</fig>
<fig id="f3-mmr-25-05-12681" position="float">
<label>Figure 3.</label>
<caption><p>Mitochondrial calcium overload induced by OGD. (A) OGD-stimulated calcium overload in the mitochondria of N2a cells (scale bars, 5 &#x00B5;m). (B and C) Western blot analysis revealed that OGD upregulated GRP75 expression in (B) HT22 and (C) N2a cells. (D) Western blot analysis revealed that OGD upregulated GRP75 expression in the MCAO tissue. (E) Western blot analysis was used to determine HIF1&#x03B1; expression in N2a cells. Representative images are provided and quantitative results are expressed as the mean &#x00B1; standard error of the mean of each group from three separate experiments. &#x002A;&#x002A;P&#x003C;0.01, &#x002A;&#x002A;&#x002A;P&#x003C;0.001, &#x002A;&#x002A;&#x002A;&#x002A;P&#x003C;0.0001 vs. Ctrl. GRP75, 75 kDa glucose-regulated protein; Ctrl, control; OGD, oxygen-glucose deprivation; MCAO, middle cerebral artery occlusion; HIF, hypoxia-inducible factor.</p></caption>
<graphic xlink:href="mmr-25-05-12681-g02.tif"/>
</fig>
<fig id="f4-mmr-25-05-12681" position="float">
<label>Figure 4.</label>
<caption><p>Inhibition of GRP75 by pharmacological agent preserves mitochondria morphology and function under OGD. (A) Western blot analysis revealed that MKT077 regulated GRP75 expression in HT22 cells. (B) Treatment with MKT077 to inhibit GRP75 mitigated the OGD-stimulated calcium overload in the mitochondria of Na2 cells. (C) Fluorescence imaging analysis of mitochondrial morphology of HT22 cells (scale bars, 5 &#x00B5;m). (D) Mitochondrial function in N2a cells from the different groups. Representative images are provided and quantitative data are expressed as the mean &#x00B1; standard error of the mean of each group from three separate experiments. &#x002A;&#x002A;P&#x003C;0.01, &#x002A;&#x002A;&#x002A;&#x002A;P&#x003C;0.0001 vs. Ctrl; <sup>#</sup>P&#x003C;0.05, <sup>##</sup>P&#x003C;0.01, <sup>####</sup>P&#x003C;0.0001 vs. OGD group. n.s., no significance; GRP75, 75 kDa glucose-regulated protein; Ctrl, control; OGD, oxygen-glucose deprivation.</p></caption>
<graphic xlink:href="mmr-25-05-12681-g03.tif"/>
</fig>
<fig id="f5-mmr-25-05-12681" position="float">
<label>Figure 5.</label>
<caption><p>Knockdown of GRP75 preserves mitochondrial morphology and function under OGD. (A) Western blot analysis confirmed siRNA-mediated knockdown of GRP75 expression in N2a cells. (B) Treatment with siRNA targeting GRP75 to inhibit GRP75 mitigated the OGD-stimulated calcium overload in the mitochondria of N2a cells. (C) Fluorescent imaging analysis of mitochondrial morphology of N2a cells (scale bars, 5 &#x00B5;m). The average length of mitochondria, number of long mitochondria per cell and average number of mitochondria per cell were determined. (D) Mitochondrial function in N2a cells from the different groups; the relative ATP content (left panel), mitochondrial membrane potential (relative to red/green fluorescence, middle panel) and relative content of ROS (right panel) were determined. Representative images are provided and quantitative data are expressed as the mean &#x00B1; standard error of the mean of each group from three separate experiments. &#x002A;&#x002A;P&#x003C;0.01, &#x002A;&#x002A;&#x002A;P&#x003C;0.001, &#x002A;&#x002A;&#x002A;&#x002A;P&#x003C;0.0001 vs. Ctrl; <sup>#</sup>P&#x003C;0.05, <sup>##</sup>P&#x003C;0.01, <sup>####</sup>P&#x003C;0.0001 vs. OGD group. Ctrl, control; OGD, oxygen-glucose deprivation; GRP75, 75 kDa glucose-regulated protein; siRNA, small interfering RNA; long-mito, long mitochondria with a length/diameter ratio of &#x003E;2; ROS, reactive oxygen species.</p></caption>
<graphic xlink:href="mmr-25-05-12681-g04.tif"/>
</fig>
<fig id="f6-mmr-25-05-12681" position="float">
<label>Figure 6.</label>
<caption><p>Schematic illustrating that preserving mitochondrial function by inhibiting GRP75 ameliorates neuron injury under ischemic stroke. Ischemia or OGD may also upregulate GRP75 expression to promote mitochondrial calcium overload, thus causing mitochondrial dysfunction and neuron death. Treatment with MKT077 or siRNA may inhibit GRP75 activation or expression and attenuate the ischemia- or OGD-induced mitochondrial calcium overload in neurons. GRP75, 75 kDa glucose-regulated protein; siRNA, small interfering RNA; OGD, oxygen-glucose deprivation; MCAO, middle cerebral artery occlusion.</p></caption>
<graphic xlink:href="mmr-25-05-12681-g05.tif"/>
</fig>
</floats-group>
</article>
